Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Archive ouverte

Chéret, A | Nembot, G | Mélard, A | Lascoux, C | Slama, L | Miailhes, P | Yeni, P | Abel, S | Avettand-Fenoel, V | Venet, A | Chaix, Ml | Molina, Jm | Katlama, C | Goujard, C | Tamalet, C | Raffi, F | Lafeuillade, A | Reynes, J | Ravaux, I | Hoën, B | Delfraissy, Jf | Meyer, L | Rouzioux, C | Group, Optiprim Anrs Study

Edité par CCSD ; New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001- -

International audience

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion